Intra Cellular Therapies shares owned by Bellevue Asset Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Bellevue Asset Management
from 13F filings
Historical chart of Bellevue Asset Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Bellevue Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.1k | 30 | 69.20 |
| 2023-12-31 | $2.1k | 30 | 71.60 |
| 2023-09-30 | $1.6k | 30 | 52.07 |
| 2023-06-30 | $1.9k | 30 | 63.30 |
| 2023-03-31 | $1.6k | 30 | 54.13 |
| 2022-12-31 | $1.6k | 30 | 52.87 |
| 2022-09-30 | $999 | 30 | 33.33 |
| 2022-06-30 | $2.0k | 30 | 66.67 |
| 2022-03-31 | $2.0k | 30 | 66.67 |